Ezetimibe and Simvastatin Tablets, 10 mg/40mg, a) 90 Tablets, b) 500 tablets, Rx only, Manufactur...

FDA Drug Recall #D-0227-2022 — Class II — October 14, 2021

Recall Summary

Recall Number D-0227-2022
Classification Class II — Moderate risk
Date Initiated October 14, 2021
Status Terminated
Voluntary Voluntary: Firm initiated

Recalling Firm

Firm Golden State Medical Supply Inc.
Location Camarillo, CA
Product Type Drugs
Quantity a) 101 b) 145 bottles

Product Description

Ezetimibe and Simvastatin Tablets, 10 mg/40mg, a) 90 Tablets, b) 500 tablets, Rx only, Manufactured by Dr. Reddy's Laboratories LA LLC Shreveport, LA 71106 USA, Packaged by GSMS, Incorporated Camarillo, CA 93012 USA; NDC: a) 51407-192-90, b) 51407-192-05

Reason for Recall

Failed Excipient Specifications and Presence of Foreign Tablets/Capsules; product manufactured using an excipient found to be OOS for conductivity and some Ezetimibe and Simvastatin Tablets, 10 mg/10 mg were found in the bottle

Distribution Pattern

Distributed to two distributors located in AZ and MO

Lot / Code Information

a) Lot: GS038610, Exp: 01/2023; b) GS038891, Exp: 1/2023

Other Recalls from Golden State Medical Supply Inc.

Recall # Classification Product Date
D-0235-2026 Class II Baclofen Tablets USP, 10 mg, 1000-count bottles... Nov 26, 2025
D-0158-2026 Class II NIACIN Extended-Release Tablets, USP, 1,000 mg,... Oct 20, 2025
D-0287-2025 Class II PRASUGREL TABLETS, 5 mg, 30 tablet bottles, Rx ... Mar 5, 2025
D-0568-2024 Class II Duloxetine Delayed-Release Capsules, USP, 30mg,... May 13, 2024
D-0349-2024 Class II Fluticasone Propionate Nasal Spray USP, 50 mcg ... Feb 14, 2024

Frequently Asked Questions

Stop taking the medication and contact your pharmacist or doctor immediately. For Class I recalls, this is urgent. For Class II or III recalls, consult your doctor before stopping — abruptly discontinuing certain medications (blood pressure drugs, antidepressants, diabetes medications) can be more harmful than continuing while arranging a replacement. Check whether the recall applies to your specific lot number and expiration date. Return the product to your pharmacy and report any adverse effects to FDA MedWatch at 1-800-FDA-1088.

Not necessarily. Many drug recalls are initiated because of quality system failures or test results that suggest a product might not meet specifications — even if no patients have reported harm. The FDA uses a precautionary approach: if there is reason to believe quality standards were not met, a recall is required regardless of whether adverse effects have been reported. Class I recalls typically involve a reasonable probability of harm; Class II recalls may cause temporary health issues; Class III recalls are for products unlikely to cause adverse health consequences but that still violate regulations.

Pharmacies typically receive recall notices directly from drug wholesalers and manufacturers within days of the recall being announced. Your pharmacist can look up whether any product in your prescription history matches a recalled lot number. For current recalls, the FDA publishes updates at FDA.gov/safety/recalls-market-withdrawals-safety-alerts and sends MedWatch email alerts for significant drug safety issues. You can sign up for MedWatch alerts at FDA.gov. Most major pharmacy chains also have their own recall notification systems that automatically alert pharmacists when a recalled product is in their inventory.

What Should You Do?

Stop using this medication if affected by this recall. Contact your pharmacist or prescribing doctor immediately for guidance. Do not flush medications — use a drug take-back program.